P H SHAW
Overview
Explore the profile of P H SHAW including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
SHAW P, Olszewski M, Kletzel M
J Hematother Stem Cell Res
. 2001 Jul;
10(3):391-403.
PMID: 11454314
Umbilical cord blood (UCB) is now commonly used as a source of stem cells for hematopoietic reconstitution following myeloablative therapy in patients with a variety of diseases. Although UCB is...
2.
Haut P, Kovarik P, SHAW P, Walterhouse D, Jenson H, Kletzel M
Bone Marrow Transplant
. 2001 May;
27(7):761-5.
PMID: 11360119
Epstein-Barr virus-associated post-transplant lymphoproliferative disorder (PTLD) has been well described as a complication following allogeneic stem cell transplantation but has only recently been reported following umbilical cord blood (UCB) transplant....
3.
SHAW P, Mancini A, McConnell J, Brown D, Kletzel M
Bone Marrow Transplant
. 2001 Mar;
27(1):101-5.
PMID: 11244446
Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder of porphyrin metabolism in which the genetic defect is the deficiency of uroporphyrinogen III cosynthase (UIIIC). Deficiency of this enzyme...
4.
SHAW P, Cohn S, Morgan E, Kovarik P, Haut P, Kletzel M, et al.
Cancer
. 2001 Mar;
91(4):642-6.
PMID: 11241229
Background: Natural killer (NK) cell lymphomas are rapidly fatal malignancies that to the authors' knowledge are rare in children. In the current study, the authors report the cases of two...
5.
Kostic C, SHAW P
Oncogene
. 2000 Aug;
19(35):3978-87.
PMID: 10962554
The EB-1 cell line is a stable transfectant of EB, a p53 null colon carcinoma cell line, with an inducible promoter controlling expression of a wild type p53 cDNA. The...
6.
SHAW P, Brown D, Shulman S
Pediatr Infect Dis J
. 2000 May;
19(5):475-7.
PMID: 10819349
No abstract available.
7.
SHAW P, Haut P, Olszewski M, Kletzel M
Pediatr Transplant
. 1999 Nov;
3(4):315-21.
PMID: 10562977
Hematopoietic stem-cell transplantation (HSCT) is an effective mode of therapy in pediatrics for the treatment of both malignant and non-malignant disorders. We compared the course of children transplanted with unrelated...
8.
SHAW P
Pathol Res Pract
. 1996 Jul;
192(7):669-75.
PMID: 8880867
The tumor suppressor gene p53, implicated in diverse types of human tumors, functions both as a gene-specific transcription factor as well as a specific inhibitor of the transcription of certain...
9.
Billotte J, SHAW P
Schweiz Rundsch Med Prax
. 1994 May;
83(20):604-8.
PMID: 8209130
PCR can be used at different levels in oncology as many examples illustrate. Interchromosomal translocations that can be detected by PCR are very specifically found i.e. in follicular lymphomas. In...
10.
SHAW P, Tamone F, Schibler U
Gene
. 1989 Dec;
84(2):371-81.
PMID: 2558970
We describe a direct procedure for screening genomic recombinant DNA libraries or restriction fragments of cloned DNA regions for RNA polymerase II promoters. Cellular polyadenylated mRNA is chemically de-capped by...